Does Dr. SAURABH AGGARWAL have financial conflicts of interest?

Dr. SAURABH AGGARWAL (MD) has received a total of $83,686 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $83,686 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SAURABH AGGARWAL?

According to CMS Open Payments data, Dr. SAURABH AGGARWAL received funding from MERCK SHARP & DOHME ($44,225), NOVO NORDISK ($23,435), and ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($12,791).

Does Dr. SAURABH AGGARWAL receive research grants or speaking fees?

Dr. SAURABH AGGARWAL has received $83,686 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SAURABH AGGARWAL

MDReal-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: ORLANDO, FL 32825

NPI Number: 1396032751

LIFETIME INDUSTRY VALUE

$83,686

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AGGARWAL is a verified Internal Medicine, Cardiovascular Disease practitioner based in ORLANDO, FL.

Between 2021 and 2024, Dr. AGGARWAL had an overall industry promotional and research financial footprint of $83,686 as recorded in the federal CMS Open Payments database.

$83,686 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGGARWAL's primary funding source is MERCK SHARP & DOHME, which accounts for $44,225 (representing 52.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

MERCK SHARP & DOHME

Rank 1

$44,225

52.8%

NOVO NORDISK

Rank 2

$23,435

28%

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 3

$12,791

15.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.